InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,221.42
(
0.00%
)
US TECH 100
17,678.80
(
-0.25%
)
Dow Jones
39,431.51
(
0.00%
)
Brent Oil
82.63
(
-0.70%
)
Bitcoin
61,566.00
(
-2.12%
)
Post# of 2338866
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Let's Roll

Send PM Follow Ignore
Followers 883
Posts 304355
Boards Moderated 5
Alias Born 06/09/2006

Let's Roll

Re: None

Friday, 10/06/2017 11:50:10 AM

Friday, October 06, 2017 11:50:10 AM

Post# of 2338866
$AEPP According to Florida Hospital, approximately 80,000 women receive a gynecological cancer diagnosis in the United States each year. About half of all gynecological cancer diagnoses are uterine cancer, which contributes to 8,000 deaths each year while ovarian cancer causes 16,000 deaths annually. Oncolix saw a need for an improvement in the current treatment protocol, thus arose Prolanta (G129R).
http://smallcapvoice.com/blog/oncolix-creates-a-drug-that-could-change-gynecological-cancer-treatment/

Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up